205 related articles for article (PubMed ID: 15201190)
1. Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming.
Saetrom P
Bioinformatics; 2004 Nov; 20(17):3055-63. PubMed ID: 15201190
[TBL] [Abstract][Full Text] [Related]
2. Expressing functional siRNAs in mammalian cells using convergent transcription.
Tran N; Cairns MJ; Dawes IW; Arndt GM
BMC Biotechnol; 2003 Nov; 3():21. PubMed ID: 14604435
[TBL] [Abstract][Full Text] [Related]
3. Computational models with thermodynamic and composition features improve siRNA design.
Shabalina SA; Spiridonov AN; Ogurtsov AY
BMC Bioinformatics; 2006 Feb; 7():65. PubMed ID: 16472402
[TBL] [Abstract][Full Text] [Related]
4. RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching.
Jiang P; Wu H; Da Y; Sang F; Wei J; Sun X; Lu Z
Comput Methods Programs Biomed; 2007 Sep; 87(3):230-8. PubMed ID: 17644215
[TBL] [Abstract][Full Text] [Related]
5. Prediction of siRNA knockdown efficiency using artificial neural network models.
Ge G; Wong GW; Luo B
Biochem Biophys Res Commun; 2005 Oct; 336(2):723-8. PubMed ID: 16153609
[TBL] [Abstract][Full Text] [Related]
6. A comparison of siRNA efficacy predictors.
Saetrom P; Snøve O
Biochem Biophys Res Commun; 2004 Aug; 321(1):247-53. PubMed ID: 15358242
[TBL] [Abstract][Full Text] [Related]
7. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
8. Improved and automated prediction of effective siRNA.
Chalk AM; Wahlestedt C; Sonnhammer EL
Biochem Biophys Res Commun; 2004 Jun; 319(1):264-74. PubMed ID: 15158471
[TBL] [Abstract][Full Text] [Related]
9. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW
Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492
[TBL] [Abstract][Full Text] [Related]
10. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.
Senn C; Hangartner C; Moes S; Guerini D; Hofbauer KG
Eur J Pharmacol; 2005 Oct; 522(1-3):30-7. PubMed ID: 16213482
[TBL] [Abstract][Full Text] [Related]
11. Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors.
Rubenstein M; Tsui P; Guinan P
Med Hypotheses; 2005; 65(5):905-7. PubMed ID: 16023790
[TBL] [Abstract][Full Text] [Related]
12. Efficient prediction methods for selecting effective siRNA sequences.
Takasaki S
Comput Biol Med; 2010 Feb; 40(2):149-58. PubMed ID: 20022002
[TBL] [Abstract][Full Text] [Related]
13. RNA interference detected 20 years ago?
Schmidt FR
Nat Biotechnol; 2004 Mar; 22(3):267-8. PubMed ID: 14990942
[No Abstract] [Full Text] [Related]
14. The impact of target site accessibility on the design of effective siRNAs.
Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells.
Miyagishi M; Hayashi M; Taira K
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):1-7. PubMed ID: 12691531
[TBL] [Abstract][Full Text] [Related]
16. Approaches for the sequence-specific knockdown of mRNA.
Scherer LJ; Rossi JJ
Nat Biotechnol; 2003 Dec; 21(12):1457-65. PubMed ID: 14647331
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion.
Zhao HF; L'Abbé D; Jolicoeur N; Wu M; Li Z; Yu Z; Shen SH
Nat Methods; 2005 Dec; 2(12):967-73. PubMed ID: 16299483
[TBL] [Abstract][Full Text] [Related]
18. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
19. Long-term RNA interference from optimized siRNA expression constructs in adult mice.
Wooddell CI; Van Hout CV; Reppen T; Lewis DL; Herweijer H
Biochem Biophys Res Commun; 2005 Aug; 334(1):117-27. PubMed ID: 15993838
[TBL] [Abstract][Full Text] [Related]
20. siRNA-mediated antitumorigenesis for drug target validation and therapeutics.
Lu PY; Xie FY; Woodle MC
Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
